profit from every $100 of sales.
$0$100
Health In Tech
$0.40-26.12% today
-74.8% in 1 year
1-year low $0.401-year high $2.03
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $20.20 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Health In Tech sold, what it kept, and what it did with the cash.
Sales went from $5.77 million in 2022 to $33.3 million in 2025, with $1.28 million of profit last year.
SalesProfit
Health In Tech vs. similar companies
Health In Tech grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Health In Tech | 20.2× · Fair price | ||
 SAP | 34.4× · Expensive | ||
 Quhuo | No profit yet | ||
 Shopify | 153.7× · Very expensive | ||
 Salesforce | 24.0× · Fair price |
AI analysis
An AI analyst reads Health In Tech's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 6 | 19 | 19 | 33 | |
| 5 | 17 | 15 | 21 | |
| 0 | 3 | 1 | 2 | |
| 0 | 4 | 2 | 3 | |
| 0 | 2 | 1 | 1 | |
| 0.00 | 0.05 | 0.01 | 0.02 | |
| 94.2% | 88.0% | 79.2% | 62.8% | |
| 3.6% | 17.7% | 5.1% | 4.6% | |
| 1.4% | 12.9% | 3.4% | 3.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 29 | 12 | 16 | 23 |
| Cash | 1 | 2 | 8 | 8 |
| Total debt | 0 | 2 | 0 | 0 |
| Total liabilities | 27 | 5 | 3 | 6 |
| 1 | 6 | 13 | 17 | |
| 54 | 54 | 55 | 58 | |
| 11.9% | 33.8% | 8.2% | 7.7% | |
| 7.6% | 40.6% | 5.1% | 7.5% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 2 | 2 | 3 | |
| 1 | 1 | 1 | 3 | |
| -0 | 0 | 1 | -0 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 0 | 0 | 2 |
Valuation
- 20.2×
- 39.6×
- 0.15
- 5.1×
- 0.8×
- –
- 7.1×
- -0.2%
- 5.0%
- 0.0%
Profitability
- 62.8%
- 4.6%
- 3.8%
- 7.7%
- 6.5%
- 12.3%
- 7.9%
- 5.5%
- 8.5%
- 4.7%
Growth
- +79.4%
- +138.5%
- −104.4%
- –
- +1.1%
Financial health
- -2.9×
- 0.01
- 0.6%
- –
- 3.13
- 3.13
- 1.44
How it ranks in Technology
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 45%of 964
Bottom 34%of 972
Top 31%of 727
Top 2%of 977
Bottom 23%of 981
What analysts expect
- Average price target
- $4.00
- Range
- $4.00 – $4.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.03 | -0.03 | −12.5% |
| Mar 25, 2026 | -0.03 | -0.04 | +25.0% |
| Nov 10, 2025 | 0.01 | 0.01 | +0.0% |
| Jul 21, 2025 | 0.01 | 0.01 | +0.0% |
| Apr 14, 2025 | 0.01 | 0.02 | −50.0% |
| Mar 18, 2025 | 0.01 | – | – |
| Dec 31, 2024 | -0.00 | – | – |
| Jun 30, 2024 | 0.01 | – | – |
News
GLP-1s can save health system money if priced below $350 a month: analysisSeeking Alpha · Nov 14, 2026How to figure out a key question this open-enrollment season: Are you overpaying for health insurance?MarketWatch · Nov 13, 2026Arm Stock Took a Hit Because Investors Fear Nvidia Might Poach Its CEO. Is It Time to Sell?Yahoo Finance · Nov 13, 20263 Favorite Warren Buffett Stocks Hit Record Highs As Nvidia SinksYahoo Finance · Nov 13, 2026Stock Market Midday, Nov. 13: Nasdaq Plunges as Nvidia Turmoil Deepens and Treasury Yields Hit 5%Yahoo Finance · Nov 13, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
50No pass
Benjamin Graham
64Pass
Philip Fisher
71Pass
Peter Lynch
96Pass
Joel Greenblatt
40No pass
Charlie Munger
48No pass
Terry Smith
41No pass
Questions about Health In Tech
Is Health In Tech a good stock to buy?
A business with weak numbers at a fair price. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Health In Tech AI analysis
What does Health In Tech do?
Health In Tech, Inc. operates as an insurance technology platform company. It is in Software - Application.
Does Health In Tech pay a dividend?
No. Health In Tech does not pay a dividend at the moment.
Is Health In Tech stock halal?
No. Health In Tech does not pass our halal screen: its cash and receivables are 49% of its market value, at or above the 49% limit. How we check
How has Health In Tech stock done over the past year?
Down 74.8% over the past twelve months, to $0.40. It traded between $0.40 and $2.03 and is 80.5% below its high.
Who are Health In Tech's competitors?
The largest listed companies in the same industry are SAP, Quhuo, Shopify and Salesforce. The peers table on this page compares their profit, growth and price with Health In Tech's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.